Skip to content

Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population

Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029602
Enrollment
Unknown
Registered
2020-02-06
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

Hubei Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Conforming to the diagnostic criteria for the above close contacts; 2. Aged between 18 and 65 years old; 3. Signing the generalized informed consent form. (The intervention objects is incorporated in the clinical study as desired).

Exclusion criteria

Exclusion criteria: 1. Severe or critically severe patients; 2. Clear evidence of bacterial infection; 3. Patients with severe primary diseases such as heart, kidney, lung, endocrine, blood, metabolism, and gastrointestinal tract, etc., may affect participation in the trial or may affect the outcome of the study by the judgment of the researcher; 4. Patients who have a family history of mental illness or have had a mental illness; 5. Patients who are allergic constitution or allergy to multiple drug; 6. pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Incidence of onset at home / designated isolation population who progressed to designated isolation treatment or were diagnosed with novel coronavirus-infected pneumonia;days of onset at home / designated isolation population who progressed to designated isolation treatment or were diagnosed with novel coronavirus-infected pneumonia;

Secondary

MeasureTime frame
body temperature;Symptom Scale;

Countries

China

Contacts

Public ContactXiaolin Tong

Hubei Provincial Hospital of TCM

Xiaolintong66@sina.com+86 13910662116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026